Works matching IS 17588340 AND DT 2009 AND VI 1 AND IP 3
Results: 6
Acknowledgements.
- Published in:
- Therapeutic Advances in Medical Oncology, 2009, v. 1, n. 3, p. 207, doi. 10.1177/1758834009353357
- Publication type:
- Article
Review: Targeted therapy in renal cancer.
- Published in:
- Therapeutic Advances in Medical Oncology, 2009, v. 1, n. 3, p. 183, doi. 10.1177/1758834009349119
- By:
- Publication type:
- Article
Review: Beyond KRAS: perspectives on new potential markers of intrinsic and acquired resistance to epidermal growth factor receptor inhibitors in metastatic colorectal cancer.
- Published in:
- Therapeutic Advances in Medical Oncology, 2009, v. 1, n. 3, p. 167, doi. 10.1177/1758834009348984
- By:
- Publication type:
- Article
Review: Predictive and prognostic markers for epidermal growth factor receptor inhibitor therapy in non-small cell lung cancer.
- Published in:
- Therapeutic Advances in Medical Oncology, 2009, v. 1, n. 3, p. 137, doi. 10.1177/1758834009347923
- By:
- Publication type:
- Article
Review: Integration of targeted agents in the neo-adjuvant treatment of gastro-esophageal cancers.
- Published in:
- Therapeutic Advances in Medical Oncology, 2009, v. 1, n. 3, p. 145, doi. 10.1177/1758834009347323
- By:
- Publication type:
- Article
Review: Adjuvant bisphosphonates in endocrine-responsive breast cancer: what is their place in therapy?
- Published in:
- Therapeutic Advances in Medical Oncology, 2009, v. 1, n. 3, p. 123, doi. 10.1177/1758834009344594
- By:
- Publication type:
- Article